LTFS
SVNT

Ladenburg Thalmann Financial Services’s SAVIENT PHARMACEUTICALS INC SVNT Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio SVNT Stock Details SVNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-50
Closed – – 4021
2013
Q3 		$0 Hold
50
– – ﹤0.01% 3973
2013
Q2 		$0 Buy
+50
New +$35 ﹤0.01% 3775

Other funds holding SVNT

Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
FHC
First Heartland Consultants Lake St. Louis, Missouri $1.55B AUM 20.5% 1-Year Est. Return
PSC
Prentiss Smith & Co Brattleboro, Vermont $182M AUM 26.44% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

Ladenburg Thalmann Financial Services's SVNT Position: Q4 2013 in Review

Ladenburg Thalmann Financial Services sold out of SAVIENT PHARMACEUTICALS INC (SVNT) in Q4 2013, closing a stake of 50 shares.

Ladenburg Thalmann Financial Services first reported a position in SVNT in Q2 2013 and held it in 2 quarters. The position peaked at $0 in Q3 2013. 7 funds tracked by Wall St. Rank hold SVNT as of Q4 2013.

  • Ladenburg Thalmann Financial Services reported no remaining SAVIENT PHARMACEUTICALS INC position as of Q4 2013 after selling out during the quarter.
  • Ladenburg Thalmann Financial Services sold 50 SAVIENT PHARMACEUTICALS INC shares in Q4 2013.
  • Ladenburg Thalmann Financial Services first reported a position in SAVIENT PHARMACEUTICALS INC in Q2 2013 and held it in 2 quarters.
  • Ladenburg Thalmann Financial Services's SAVIENT PHARMACEUTICALS INC position peaked at $0 in Q3 2013.
  • 7 funds tracked by Wall St. Rank held SAVIENT PHARMACEUTICALS INC as of Q4 2013.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2013, filed 14 Feb 2014.